发明名称 |
Treating cardiac infarction-induced damage to myocardium, using moxonidine to restore or rehabilitate myocardial state after infarction |
摘要 |
4-Chloro-5-((4,5-dihydro-1H-imidazol-2-yl)-amino)-2-methylpyrimidine (I) (i.e. moxonidine) or its acid addition salt is used for the preparation of a medicament for treating cardiac infarction-induced damage to the myocardium. An Independent claim is also included for the preparation of a pharmaceutical composition for use as above, by converting (I) or its acid addition salt, together with conventional auxiliaries, into a suitable dosage form.
|
申请公布号 |
DE10003771(A1) |
申请公布日期 |
2000.08.03 |
申请号 |
DE2000103771 |
申请日期 |
2000.01.28 |
申请人 |
SOLVAY PHARMACEUTICALS GMBH |
发明人 |
SCHOEMAKER, REGINA GEERTRUIDA |
分类号 |
C07D403/12;A61K31/506;A61P9/10;(IPC1-7):A61K31/505 |
主分类号 |
C07D403/12 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|